Innovative Global Diabetic Cure Limited - Company Profile

It is a healthcare public limited company based in Mohali, Punjab, India, established in 2014.

2014 Mohali, Punjab, India Struck Off

Last Updated: July 26, 2025

About Innovative Global Diabetic Cure Limited

Innovative Global Diabetic Cure Limited, a struck off public limited company, was established on 20 March 2014 in Mohali, Punjab, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85110PB2014PLC038510. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹0.50 M.

Its leadership includes Bhupinder Kumar (Director), Som Gupta Kumar (Director), Makhan Singh (Director). Past directors included Sreekant Ramachar Holehonnur. It is based at Sco No. -12, Phase Ix Industrial Area, Sas Nagar, Mohali, Punjab, 160062.

Company Details

CIN/LLPIN
U85110PB2014PLC038510
Registration Number
038510
Incorporation Date
20 March 2014
Authorized Capital
₹2.00 Cr
Paid-Up Capital
₹0.50 M
ROC Code
Roc Chandigarh
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 2.00 Cr as on 26-07-2025
Paid Up Capital ₹ 0.50 M as on 26-07-2025
Company Age 11 Year, 11 Months

Comprehensive Company Insights

Explore comprehensive insights into Innovative Global Diabetic Cure Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Innovative Global Diabetic Cure Limited?

Current Directors

Name	Designation	Appointment Date	Status
Bhupinder Kumar	Director	20 Mar 2014	Current
Som Gupta Kumar	Director	20 Mar 2014	Current
Makhan Singh	Director	23 Jul 2014	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	23 Jul 2014	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Innovative Global Diabetic Cure.

Enhance accessibility to Innovative Global Diabetic Cure's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Innovative Global Diabetic Cure?

Unlock access to Innovative Global Diabetic Cure's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Innovative Global Diabetic Cure?

Unlock and access historical data on people associated with Innovative Global Diabetic Cure, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Innovative Global Diabetic Cure, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovative Global Diabetic Cure's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Innovative Global Diabetic Cure

Recent Activity within the Organization

Director Appointment

Progress on Makhan Singh was appointed as a Director was appointed as a Director on 23 Jul 2014 & has been associated with this company since 11 years 7 months . was documented.
23 Jul 2014
Director Appointment

The activity Bhupinder Kumar was appointed as a Director was appointed as a Director on 20 Mar 2014 & has been associated with this company since 11 years 11 months . was completed.
20 Mar 2014
Director Appointment

The activity Som Gupta Kumar was appointed as a Director was appointed as a Director on 20 Mar 2014 & has been associated with this company since 11 years 11 months . was completed.
20 Mar 2014
Company Incorporation

Innovative Global Diabetic Cure Limited was registered on 20 Mar 2014 with Roc Chandigarh & aged 11 years 11 months as per MCA records. was recorded as a recent event.
20 Mar 2014

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Innovative Global Diabetic Cure Limited?

The CIN of Innovative Global Diabetic Cure Limited is U85110PB2014PLC038510.

Where is Innovative Global Diabetic Cure Limited headquartered?

Innovative Global Diabetic Cure Limited is headquartered at Sco No. -12, Phase Ix Industrial Area, Sas Nagar, Mohali, Punjab, 160062.

When was Innovative Global Diabetic Cure Limited incorporated?

Innovative Global Diabetic Cure Limited was incorporated on 20 March 2014.

Who are the current directors of Innovative Global Diabetic Cure Limited?

The current directors of Innovative Global Diabetic Cure Limited are

What is the primary industry of Innovative Global Diabetic Cure Limited?

The primary industry of Innovative Global Diabetic Cure Limited is Healthcare.

Is Innovative Global Diabetic Cure Limited a listed company?

Innovative Global Diabetic Cure Limited is unlisted.

What is the capital structure of Innovative Global Diabetic Cure Limited?

The authorized capital of Innovative Global Diabetic Cure Limited is ₹2.00 Cr, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available